SEC Company Response from PENSON WORLDWIDE INC (CIK 0001123541) — Sep 23, 2005
PENSON WORLDWIDE INC (CIK 0001123541)
Date: Sept. 23, 2005 · CIK: 0001123541 · Accession: 0000950134-05-018291
AI Filing Summary & Sentiment
File numbers found in text: 333-127385
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
<PAGE>
September 23, 2005
VIA EDGAR TRANSMISSION AND FACSIMILE
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, D.C. 20549
Attn: Mr. Todd K. Schiffman, Esq.
RE: PENSON WORLDWIDE, INC. REGISTRATION STATEMENT ON FORM S-1
FILED AUGUST 10, 2005
FILE NO. 333-127385
Dear Mr. Schiffman:
We are writing on behalf of Penson Worldwide, Inc. (the "Company"), in
response to the letter of comments from the Staff of the Securities and Exchange
Commission to the Company dated September 9, 2005 (the "Comment Letter"), with
respect to the Company's Registration Statement on Form S-1, File No. 333-127385
(the "Registration Statement"). We are filing Amendment No. 3 to the
Registration Statement ("Amendment No. 3") in response to your Comment Letter.
The numbered paragraphs below restate the numbered paragraphs in the Comment
Letter in italics, and the discussion set out below each such paragraph is the
Company's response to the Staff's comment.
General
1. We will process your amendment with missing information (e.g., pricing
on cover page, offering on page 7, aggregated option exercises on page
73, underwriting on page 99, Item 13 on page II-1, etc.). Since this
missing information triggers a number of disclosure matters, we will
need sufficient time to process the amendment when it is included.
Please understand that its effect on disclosure throughout the document
may cause us to raise issues in areas not previously commented on.
The Company notes the Staff's comment.
2. Please revise your disclosure to provide a brief description of
industry terms such as algorithmic trading and Level II market
information, or refer the reader to the location where you define such
terms.
In response to the Staff's comment, the Company has included a brief
statement on page 1 of Amendment No. 3 referring the reader to the
"Glossary of selected terms" where certain industry terms related to
the Company's business are
1.
<PAGE>
discussed. The Company has also included additional terms in the
"Glossary of selected terms."
3. Please revise your disclosure to address your code of ethics. Refer to
Item 406 of Regulation S-K.
The Company advises the Staff that it adopted a code of ethics on July
26, 2005, and has added a reference on page 74 to its code of ethics.
Market opportunity, page 3
4. Please balance the discussion with a reference to the recent problems
you have experienced in the UK market.
In response to the Staff's comment, on page 4 the Company has revised
its discussion of the opportunities in the Canadian and European
markets to reference the recent difficulties it has experienced in
implementing its operational plan in the U.K. In addition, the Company
has expanded its discussions of the challenges it has faced in the U.K.
market beginning on page 15 of the "Risk Factors" section.
Recent Developments, page 5
5. Please revise to describe, or refer the reader to where in the
prospectus that you discuss, the terms (including price, possible
impact on financial performance and relevant risks and benefits) of
your acquisition of CCS, Nexa Technologies and other entities. For
example, the Stock Purchase Agreement by and among SAI Holdings, Inc.,
Computer Clearing Services, Inc., and the Selling Stockholders includes
the Closing Date Payment, defined as Book Value plus one million
dollars; however, it is unclear how much the Book Value is worth.
The Company has added a cross reference on page 6 to refer the reader
to its risk factor on acquisitions and to its new discussion on
acquisitions in the "Overview" section of the MD&A. The Company has
also added a new disclosure on page 31 of the MD&A to discuss the terms
of the CCS and Nexa acquisitions, as requested by the Staff.
Risk Factors
Risks related to our Business and industry
We depend on a limited number of clients for a significant portion of our...,
page 10
6. Please revise to refer the investor to your discussion of the loss of
your largest clearing correspondent in the United States (e.g., page
33).
The Company has referenced the discussion of the loss of the clearing
correspondent on page 10 of Amendment No. 3.
2.
<PAGE>
If we are unable to respond to demands of our existing and new. clients, our...,
page 14
7. Several of your risk factors discuss generic issues. For example, this
risk factor, the first two risk factors on page 15 and the middle risk
factor on page 16, could apply to most companies. Please revise such
risk factors to address risks that directly affect your company.
In response to the Staff's comment, the Company has revised the risk
factors referenced above which appear on pages 14-16 to describe how
the risks directly affect the Company.
Risks related to this offering and our requirements as a public company
New investors will suffer immediate and substantial dilution in the tangible...,
page-21
8. Please revise to refer the investor to the relevant sections regarding
dilution, such as "Capitalization" and "Dilution" on, pages 25 and 26,
respectively.
In response to the Staff's comment, the Company has revised the risk
factors on page 23 to refer to the relevant sections regarding
dilution.
Management's discussion and analysis of financial condition and results of...,
page 29
9. The discussion and analysis of known trends, demands, commitments,
events and uncertainties help in an understanding a company's
performance. Please revise to discuss trends, such as the decreasing
revenues in dollar terms from 2000 to 2002, the fall in net revenues
from clearing operations and the rise in interest income from 2002 to
2004 discussed in the second paragraph on page 31, the quarterly rise
in technology revenues and interest expense on page 40, or any other
material known trends and uncertainties regarding your financial
condition and the results of operations. Refer to III.B.3 of Release
Number 33-8350 regarding MD&A, dated December 29, 2003.
In response to the Staff's comment, the Company has revised its
discussion and analysis of the material known trends, including the
trends noted by the Staff, on page 30 of the MD&A.
10. Please revise your discussion to more specifically address your
negative cash flows from operations in 2004. More clearly disclose the
reasons for this trend in operating cash flows. Disclose the steps you
intend to take to address this trend, and identify the extent to which
those steps have been implemented. Refer to Item 303(a)(1) of
Regulation S-K.
In response to the Staff's comment, the Company has added a statement
in the "Overview" section of the MD&A to note the Company's continuing
need for additional capital. The need is not as great as would be
suggested by the Consolidated Statement of Cash Flows, as described
below. The Company has also revised its discussion in the "Liquidity
and capital resources" section of MD&A to address the unusual number
for 2004 in its Consolidated Statement of
3.
<PAGE>
Cash Flows, and to explain that its growing business has had a need for
additional cash since 2002. It is the Company's understanding that GAAP
requires that statements of cash flows be prepared in a manner such
that short term bank borrowings are shown in the "financing activities"
section, while other sources of cash to fund customer requirements for
liquidity, such as stock loans, are shown in the "operating activities"
section. It is this GAAP requirement that has generated the unusual
number in 2004 on the "net cash used in operating activities" line. The
Company understands that this is a fairly common issue for financial
sector companies. However, the existing GAAP requirements are not
flexible in this regard. As noted in the Company's revised disclosure,
the Company's actual need for additional capital is continuing but is
much more modest than the 2004 number would suggest.
Overview, page 32
11. You state on page 15 that you embarked upon an aggressive plan to roll
out additional products and services in the U.K. in the fall of 2004
and that the implementation of this roll-out was not successful. Either
here or elsewhere as appropriate, provide a detailed discussion of the
performance problems in the UK and the revisions to your operational
plan and revise your MD&A to more clearly disclose this U.K. roll-out.
Disclose the steps being taken to correct this roll-out implementation,
and quantify the impact of this situation, both in terms of losses
incurred and additional costs you expect to incur to correct it.
In response to the Staff's comment, the Company has added a detailed
discussion of the performance problems in the U.K. and the information
requested by the Staff on pages 15, 16 and 34.
Quarterly Results of Operations, page 39
12. Please revise to discuss the reasons for the rise in employee
compensation benefits and the communications and data processing
expenses for the quarters ended December 31, 2004, March 31, 2005 and
June 30, 2005 given that these quarters immediately precede your
proposed public offering.
The Company has included a discussion of the reasons for the increase
in the two expense categories on page 42 of Amendment No. 3.
Contractual obligations and commitments, page 41
13. Your commitments and contingencies footnote on page F-18 indicates the
existence of capital leases. Please revise the schedule of obligations
and commitments on page 41 to include obligations under capital leases.
Refer to Item 303(5)(B) of Regulation S-K.
The Company has revised the schedule of obligations and commitments on
page 44 to include obligations under capital leases.
4.
<PAGE>
14. Please revise your schedule to include obligations under repurchase
agreements. Refer to Item 303 (5)(D) of Regulation S-K.
The Company has noted on page 41 that there were no amounts outstanding
under repurchase agreements at December 31, 2004. While the Company
does enter into repurchase agreements from time to time, and therefore
has an accounting policy relating to them, it did not have any
outstanding repurchase agreements for the time period shown.
Qualitative and quantitative disclosure about market risk, page 43
15. You discuss interest revenues and interest income in the section
describing your business and include a risk factor titled, "[d]ecreases
in short-term interest rates would negatively impact the profitability
of our margin lending business." Please revise your disclosure in this
section as it appears that you do have material exposure to interest
rate changes. See Item 305 of Regulation S-K.
The Company has revised the discussion of interest revenues and
interest income under "Qualitative and quantitative disclosure about
market risk" beginning on page 45 to discuss the impact of interest
rate changes.
Industry
Types of clearing arrangements, page 50
16. Please revise to describe how you fit into the industry (i.e., the
United States has three types of clearing arrangements:
fully-disclosed, omnibus clearing and facilities management programs.
In which of these do you principally compete?).
The Company has revised the discussion of types of clearing
arrangements on page 54 to describe how it fits into the industry, and
has provided a cross reference to its more detailed discussion of its
clearing operations in the "Business" section.
Securities-processing, page 56
17. Please revise to explain the SEC rules that govern your securities
lending and borrowing.
The Company has added the disclosure requested by Staff on page on
pages 60 and 66 to describe the SEC rules governing securities lending
and borrowing.
Management
Board Committees
Audit Committee, page 70
18. Please revise to identify the expert on your audit committee and review
Section 10A the Securities Exchange Act and its associated rules.
Please advise how you plan to comply and refer also to Section 301 of
the Sarbanes-Oxley Act of 2002.
5.
<PAGE>
The Company's Board of Directors intends to designate an "audit
committee financial expert" prior to the effective date of its IPO and
presently expects that it will designate Mr. David M. Kelly as such.
Once the Board of Directors has made this determination, the Company
will disclose the information in its Registration Statement. The
Company is aware of the requirements of Section 10A of the Securities
Exchange Act and its associated rules and Section 301 of the
Sarbanes-Oxley Act of 2002. The Board of Directors is in the process of
reviewing its membership and its compliance with those regulations and
will be in compliance prior to the effectiveness of its IPO.
Compensation committee interlocks and insider participation, page 70
19. Given the numerous relationships among directors, the company, its
affiliates and outside parties discussed here as well as in "Other
transactions" (promissory notes, personal guarantees, certain
relationships and transactions, etc.) starting on page 80, consider
including these as part of your disclosure on risk factors with
emphasis on potential conflicts of interests.
In response to the Staff's comment, the Company has added a reference
in its risk factor on page 22 to reference the discussion under
"Certain relationships and related transactions."
SAMCO Division and split off transaction, page 82
20. You discuss the exchange of shares on page 83 as being a tax-free
transaction, in addition to your disclosure on pages 29 and F-10
concerning tax-free transactions. Please advise how you determined that
there are no material tax consequences from your split-off.
The Company has revised the language on pages 30, 31, 86 and 87 to
clarify that the transactions were or are intended to be tax free.
Although the structure was designed to be tax free, no tax opinion was
obtained.
Description of capital stock, page 88
21. Please revise your disclosure regarding the shares of preferred stock
to include a detailed description of the rights, privileges, and
conversion terms of this class of securities.
The Company believes that it is not appropriate to include a detailed
description